FALCIANI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 5.053
EU - Europa 4.970
AS - Asia 778
SA - Sud America 12
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
Totale 10.834
Nazione #
US - Stati Uniti d'America 5.037
GB - Regno Unito 1.533
IE - Irlanda 851
IT - Italia 850
CN - Cina 592
SE - Svezia 518
UA - Ucraina 439
DE - Germania 291
FR - Francia 216
FI - Finlandia 110
VN - Vietnam 81
ES - Italia 65
BE - Belgio 32
PL - Polonia 23
IR - Iran 22
TR - Turchia 17
CA - Canada 14
IN - India 14
HK - Hong Kong 11
AU - Australia 9
NL - Olanda 8
PK - Pakistan 8
RO - Romania 8
JP - Giappone 7
RU - Federazione Russa 7
EU - Europa 6
AT - Austria 5
PE - Perù 5
BR - Brasile 4
EG - Egitto 4
IL - Israele 4
PH - Filippine 4
SG - Singapore 4
JO - Giordania 3
RS - Serbia 3
BD - Bangladesh 2
CL - Cile 2
EE - Estonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MT - Malta 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 10.834
Città #
Southend 1.452
Dublin 843
Fairfield 661
Chandler 478
Ashburn 410
Siena 373
Jacksonville 360
Woodbridge 339
Ann Arbor 296
Seattle 267
Wilmington 265
Houston 261
Menlo Park 252
Cambridge 206
Beijing 156
Princeton 143
Nanjing 115
Dong Ket 81
Boardman 72
New York 71
Málaga 59
San Mateo 54
Florence 49
Nanchang 48
Shanghai 46
San Diego 45
Helsinki 44
Fremont 40
Dearborn 35
Brussels 31
Hebei 31
Rome 31
Shenyang 31
Redwood City 28
Bagno a Ripoli 21
Kunming 21
Tianjin 20
Washington 20
Jiaxing 16
Gdansk 14
London 14
Izmir 13
Milan 13
Ningbo 13
Changsha 12
Kansas City 12
Phoenix 12
Düsseldorf 11
Toronto 11
Zhengzhou 10
Norwalk 9
University Park 9
Chicago 8
Hangzhou 8
Jinan 8
Taizhou 8
Zanjan 8
Arezzo 7
Colle Di Val D'elsa 7
Guangzhou 7
Lancaster 7
San Francisco 7
Atlanta 6
Nürnberg 6
Tappahannock 6
Auburn Hills 5
Campagnano Di Roma 5
Lanzhou 5
Lima 5
Radomsko 5
Venezia 5
Vienna 5
Waukegan 5
Catania 4
Changchun 4
Hong Kong 4
Kilburn 4
Leawood 4
Napoli 4
Pontedera 4
Redmond 4
Timisoara 4
Amman 3
Bangalore 3
Cairo 3
Canberra 3
Capalbio 3
Castellina In Chianti 3
Como 3
Costa Mesa 3
Fucecchio 3
Fuzhou 3
Gdynia 3
Grosseto 3
Gujranwala 3
Hanover 3
Hefei 3
Lahore 3
Lappeenranta 3
Monmouth Junction 3
Totale 8.147
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 260
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 246
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 244
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 241
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 211
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 205
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 203
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 199
Tumor imaging with tetrabranched neurotensin 196
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 195
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 187
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 186
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 184
Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells 176
Branched peptides for tumor diagnosis and therapy 165
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 165
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 164
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 160
Branched Neurotensin For Tumor Targeting 159
A new NT4 peptide-based drug delivery system for cancer treatment 159
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 158
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 155
Branched peptides as bioactive molecules for drug design 154
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 152
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 151
Synthetic peptides in the form of dendrimers become resistant to protease activity 151
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 150
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 148
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 147
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 141
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 140
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 139
Nanoparticles exposing neurotensin tumor-specific drivers. 138
Branched peptides as targeting agents for tumor imaging and therapy 137
Branched multimeric peptides for tumor diagnosis and therapy 136
Bioactive peptides from libraries 135
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 135
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 133
Branched neurotensin for tumor targeting 128
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents. 127
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate. 127
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 124
Molecular basis of branched peptides resistance to enzyme proteolysis 124
Neurotensin-derived branched peptides and uses thereof 121
Tumor imaging with tetrabranched neurotensin 119
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 119
BRANCHED PEPTIDES AS THERAPEUTICS 117
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 117
The development of antimicrobial peptides as new antibacterial drugs. 117
Synthetic antidotes against snake neurotoxins 116
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 113
The antimicrobial peptide M33. An example of drug development 113
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 113
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 112
The antimicrobial peptide M33. An example of drug development 110
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 109
Branched Neurotensin peptides for tumor personalized therapy 108
Branched peptides as novel tumor-targeting agents for bladder cancer. 107
Tumor selective targeting by branched peptides 107
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 106
null 105
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 104
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 103
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 102
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 101
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 97
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 94
Branched neurotensin peptides for tumor targeting 91
Synthetic peptides in the form of dendrimers can become resistant to protease activity 90
OLIGO-BRANCHED PEPTIDES FOR TUMOR TARGETING: FROM MAGIC BULLETS TO MAGIC FORKS. 87
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 85
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 84
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 83
Synthetic inhibitors of anthrax lethal toxin 82
null 78
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 76
Dendrimeric peptides for tumor targeting 70
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 64
Peptide Drugs 63
Structurally driven selection of human hepatitis C virus mimotopes. 58
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 50
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 43
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 41
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 37
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 34
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 26
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 13
Totale 11.020
Categoria #
all - tutte 32.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 0 0 0 0 0 0 0 0 268
2019/20202.077 257 74 149 292 149 158 172 237 182 199 76 132
2020/20212.065 86 157 41 166 71 279 211 273 176 286 131 188
2021/20221.253 80 125 78 137 84 50 53 78 45 152 125 246
2022/20231.752 94 182 214 227 186 336 41 142 142 81 75 32
2023/20241.308 44 42 123 80 59 386 476 26 7 26 13 26
Totale 11.020